Showing 40,301 - 40,320 results of 132,239 for search '(( a e decrease ) OR ( 5 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 2.18s Refine Results
  1. 40301

    Image_6_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  2. 40302

    Early dendritic protrusions of Fmr1 KO mice develop normally in vitro, except for a transiently elevated density at P4–7. by Alberto Cruz-Martín (331261)

    Published 2013
    “…Images are best projections (∼5–11 optical sections, 1 µm apart). Dendrites were imaged every 60 seconds, but only a subset of time points is shown. …”
  3. 40303

    Image_1_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  4. 40304

    Table_1_Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study.DOCX by Jocelyn H. Leu (17881520)

    Published 2024
    “…Introduction<p>Nipocalimab is a high-affinity, fully human, aglycosylated, effectorless, immunoglobulin G (IgG) 1 monoclonal antibody that targets the neonatal Fc receptor (FcRn), decreases systemic IgG including autoantibodies, and is under development in several IgG autoantibody- and alloantibody-mediated diseases, including generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, maternal-fetal medicine, and multiple other therapeutic areas. …”
  5. 40305

    Image_3_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  6. 40306

    Image_2_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  7. 40307

    Image_7_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  8. 40308

    Image_4_Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression.tif by Ellise M. Johnson (12069161)

    Published 2022
    “…Most cases are successfully treated with a simple excision procedure, but ~5% of cases metastasize and have a 5-year survival rate of 25-45%. …”
  9. 40309
  10. 40310

    Characteristics of the included literature. by Wenpin Cai (13779001)

    Published 2024
    “…The relative abundance of <i>Ruminococcus</i>, <i>Faecalibacterium</i>, and <i>Coprococcus</i> all decreased, with total SMDs of -0.96 (95% CI -1.29 to -0.63, I<sup>2</sup> = 4.8%), -1.13 (95% CI -2.07 to -0.19, I<sup>2</sup> = 80.5%), and -1.66 (95% CI -3.04 to -0.28, I<sup>2</sup> = 91.5%). …”
  11. 40311

    PRISMA flow diagram. by Wenpin Cai (13779001)

    Published 2024
    “…The relative abundance of <i>Ruminococcus</i>, <i>Faecalibacterium</i>, and <i>Coprococcus</i> all decreased, with total SMDs of -0.96 (95% CI -1.29 to -0.63, I<sup>2</sup> = 4.8%), -1.13 (95% CI -2.07 to -0.19, I<sup>2</sup> = 80.5%), and -1.66 (95% CI -3.04 to -0.28, I<sup>2</sup> = 91.5%). …”
  12. 40312
  13. 40313

    Table_6_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  14. 40314

    Table_3_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  15. 40315

    Table_2_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  16. 40316

    Table_1_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.docx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  17. 40317

    Table_7_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  18. 40318

    Table_4_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  19. 40319
  20. 40320